Psychometric properties of the Croatian version of the Multiple Sclerosis Walking Scale (MSWS-12)

References

• Vidal-Jordana A, Montalban X. Multiple sclerosis: epidemiologic, clinical, and therapeutic aspects. Neuroimaging Clin N Am. 2017;27(2):195–204.
   PubMed Web of Science ®Google Scholar
• Cameron MH, Nilsagard Y. Balance, gait, and falls in multiple sclerosis. Handb Clin Neurol. 2018;159:237–250.
   PubMedGoogle Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33(11):1444–1452.
   PubMed Web of Science ®Google Scholar
• Sikes EM, Cederberg KL, Sandroff BM, et al. Quantitative synthesis of Timed 25-Foot Walk performance in multiple sclerosis. Arch Phys Med Rehabil. 2020;101(3):524–534.
   PubMed Web of Science ®Google Scholar
• Hobart JC, Riazi A, Lamping DL, et al. Measuring the impact of MS on walking ability: the 12-item MS Walking Scale (12-MSWS). Neurology. 2003;60(1):31–36.
   PubMed Web of Science ®Google Scholar
• Dib H, Tamam Y, Terzi M, et al. Testing patient-reported outcome measurement equivalence in multinational clinical trials: an exemplar using the 12-item Multiple Sclerosis Walking Scale. Mult Scler J Exp Transl Clin. 2017;3(3):2055217317728740.
   Google Scholar
• Kalron A, Ehling R, Baert I, et al. Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: secondary results from a RIMS multicenter study. Mult Scler Relat Disord. 2020;46:102511.
   PubMed Web of Science ®Google Scholar
• Pilutti LA, Dlugonski D, Sandroff BM, et al. Further validation of Multiple Sclerosis Walking Scale-12 scores based on spatiotemporal gait parameters. Arch Phys Med Rehabil. 2013;94(3):575–578.
   PubMed Web of Science ®Google Scholar
• Kim W, Park EY, Hyun JW, et al. Validation of the Korean version of the 12-item Multiple Sclerosis Walking Scale and application to neuromyelitis optica spectrum disorder. J Clin Neurol. 2020;16(2):270–276.
   PubMed Web of Science ®Google Scholar
• Solaro C, Trabucco E, Signori A, et al. Italian validation of the 12-item Multiple Sclerosis Walking Scale. Mult Scler Int. 2015;2015:540828.
   PubMed Web of Science ®Google Scholar
• Marangoni BE, Pavan K, Tilbery CP. Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population. Arq Neuropsiquiatr. 2012;70(12):922–928.
   PubMed Web of Science ®Google Scholar
• Nakhostin Ansari N, Naghdi S, Mohammadi R, et al. Multiple Sclerosis Walking Scale-12, translation, adaptation and validation for the Persian language population. Gait Posture. 2015;41(2):420–424.
   PubMed Web of Science ®Google Scholar
• Rogić Vidaković M, Šimić N, Poljičanin A, et al. Psychometric properties of the Croatian version of the Depression, Anxiety, and Stress Scale-21 and Multiple Sclerosis Impact Scale-29 in multiple sclerosis patients. Mult Scler Relat Disord. 2021;50:102850.
   PubMed Web of Science ®Google Scholar
• Hobart J, Lamping D, Fitzpatrick R, et al. The Multiple Sclerosis Impact Scale (MSIS-29); a new patient-based outcome measure. Brain. 2001;124(5):962–973.
   PubMed Web of Science ®Google Scholar
• Rosti‐Otajärvi E, Hämäläinen P, Wiksten A, et al. Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale‐29. Brain Behav. 2017;7(7):e00725.
   PubMed Web of Science ®Google Scholar
• Raffel J, Wallace A, Gveric D, et al. Patient-reported outcomes and survival in multiple sclerosis: a 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29. PLoS Med. 2017;14(7):e1002346.
   PubMed Web of Science ®Google Scholar
• Lovibond SH, Lovibond PF. Manual for the depression anxiety and stress scales. 2nd ed. Sydney: Psychology Foundation; 1995.
   Google Scholar
• Karimi S, Andayeshgar B, Khatony A. Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study. BMC Psychiatry. 2020;20(1):166.
   PubMed Web of Science ®Google Scholar
• Khatibi A, Moradi N, Rahbari N, et al. Development and validation of fear of relapse scale for relapsing-remitting multiple sclerosis: understanding stressors in patients. Front Psychiatry. 2020;11(226):226.
   PubMedGoogle Scholar
• Benedict RHB, Amato MP, Boringa J, et al. Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. BMC Neurol. 2012;12:55.
   PubMed Web of Science ®Google Scholar
• Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–286.
   PubMed Web of Science ®Google Scholar
• Einar G. Guidelines for translating and adapting psychological instruments. Nord Psychol. 2009;61(2):29–45.
   Web of Science ®Google Scholar
• Fenn J, Tan C, George S. Development, validation and translation of psychological tests. BJPsych Adv. 2020;26(5):306–315.
   Google Scholar
• Mehta L, McNeill M, Hobart J, et al. Identifying an important change estimate for the Multiple Sclerosis Walking Scale-12 (MSWS-12v1) for interpreting clinical trial results. Mult Scler J Exp Transl Clin. 2015;1:2055217315596993.
   Google Scholar
• McGuigan C, Hutchinson M. Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12). Neurology. 2004;62(11):2103–2105.
   PubMed Web of Science ®Google Scholar
• Motl RW, McAuley E, Mullen S. Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12. J Neurol Sci. 2011;305(1–2):75–79.
   PubMed Web of Science ®Google Scholar
• Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler. 2012;18(7):914–924.
   PubMed Web of Science ®Google Scholar